Progressive Supranuclear Palsy Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Subcutaneous Apomorphine in the Treatment of Progressive Supranuclear Palsy and Cortico Basal Degeneration (APOPARKA)
Conditions: Progressive Supranuclear Palsy; Corticobasal Degeneration Intervention: Drug: Apomorphine Sponsor: Fondation Ophtalmologique Adolphe de Rothschild Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2021 Category: Research Source Type: clinical trials
